Company: INMB
Filing Date: 2025-02-10
Form Type: 8-K
Source: 0001213900-25-011517
Chunk: 0

Company: Inmune Bio, Inc.
Filing Date: 2025-02-10
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01. Regulation FD Disclosure.

INmune Bio Inc. (the “ Company”) has prepared a slide deck
that the Company intends to use in presentations from time to time (the “ Investor Presentation”) and a slide deck that the
Company intends to use in webinar presentations from time to time (the “ Webinar Presentation”). Copies of the Investor Presentation
and Webinar Presentation are available at the “ Investors - Corporate Presentation” section of the Company’s website
at https://inmunebio. com/index. php/investors/corporate-presentation.

The Investor Presentation
and Webinar Presentation are furnished as Exhibit 99.1 and Exhibit 99.2 to this Current Report on Form 8-K.

The information in this Item 7.01 and Exhibit 99.1 and Exhibit
99.2 of this Current Report on Form 8-K is furnished and shall not be deemed to be “filed” for the purposes of Section
18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of
that section. The information in this Item 7.01 and Exhibit 99.1 and Exhibit 99.2 of this Current Report on Form 8-K shall not be
incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or
after the date of this Current Report on Form 8-K, regardless of any general incorporation language in any such filing.

Item 9.01 Financial Statements and Exhibits.